Pain and Smoking Study - Interactive Voice Response

Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · May 29, 2024

Keywords

ClinConnect Summary

Veterans with chronic pain represent an important population in which to focus smoking cessation efforts. Smoking cessation among patients with chronic medical illnesses substantially decreases morbidity and mortality; yet, many patients (\>50%) with chronic pain continue to smoke.

This study aims to:

1. Determine whether the existing integrated pain and smoking cessation (PASS intervention) augmented with IVR (PASS-IVR) is superior to treatment as usual (e.g., referral to standard VA smoking cessation clinic) enhanced with pharmacotherapy tele-consult (E-TAU) at 6 (primary endpoint) and ...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • being an enrolled Veteran at VACHS;
• • current tobacco use;
• • willingness to make a quit attempt;
• • significant chronic pain defined as \>/=4 on the pain intensity portion of the Brief Pain Inventory (BPI) for more than 90 days.
• Exclusion Criteria:
• • active diagnosis of dementia or psychosis in medical record;
• • severely impaired hearing or speech;
• • lack of telephone access;
• • enrollment in concurrent research study that might affect main outcomes of this study;
• • terminal illness;
• • non-English speaking;
• • pregnancy;
• • provider advising against exercise;
• • planned surgeries; and
• • clinically significant depressive symptoms (\>10 PHQ-9).

Trial Officials